EquityZen Growth Technology Fund LLC - Series 578
Raised
$1M
Investors
45
Min Invest
$10,007
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 578 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors on 2020-09-03, raising $1.2M from 45 investors under Rule 506(b) and Section 3(c)(1). The offering carries a $10K minimum investment and is part of EquityZen's pre-IPO secondary marketplace platform, which operates 1,891 related EDGAR entities providing accredited investor access to private company shares.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption pattern common to secondary marketplace platforms targeting accredited investors. The $10K minimum investment represents the accessible retail-accredited tier, consistent with EquityZen's platform model of fractionalizing access to private growth company equity through series-specific SPVs.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
